Skip to content

Genotypes of skin, hair and eye colour and mole types and distribution in melanoma patients.

Pigmentation genotypes and phenotypic correlations with dermoscopic naevus types and distribution in melanoma patients.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12616000678493
Acronym
n/a
Enrollment
56
Registered
2016-05-25
Start date
2016-05-25
Completion date
2018-06-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will examine the links between melanoma risk and the genetics controlling skin, hair and eye colour and mole type and distribution. Who is it for? You may be eligible to join this study if you are a patient of the Victorian Melanoma Service who is able to attend an appointment at the Alfred Hospital and who has had a previous or current melanoma diagnosed. People aged 18 or older are eligible. Study details All participants in this study will attend a one-off appointment where they will fill out a questionnaire about their sun exposure and medical history and give a saliva sample for DNA testing. A research assistant will record the participant's skin, hair and eye colour, weight and height and take full body images of the participant in their underwearas well as dermoscopic (close-up) images of moles larger than 5mm in diameter. This usually takes between 1 and 2 hours. We hope that this research will contribute to better melanoma screening procedures and identify people who would benefit from more frequent skin checks. Data will be combined with a similar, previously registered and ongoing study (trial ID - ACTRN12615000244505).

Interventions

Sponsors

Dr Yan Pan
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients at the Victorian Melanoma Services at Prince Alfred Hospital, with previous/current diagnosis of melanoma.

Exclusion criteria

None

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026